Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Series A
Preferred Stock
Series B
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 3,348 $ 7,254 $ 967 $ 33,221,505 $ (39,844,531) $ (6,611,457)
Balance (in Shares) at Dec. 31, 2021 334,800 725,426 9,669,217      
Stock-based compensation 200,157 200,157
Net income (loss) (3,504,002) (3,504,002)
Balance at Mar. 31, 2022 $ 3,348 $ 7,254 $ 967 33,421,662 (43,348,533) (9,915,302)
Balance (in Shares) at Mar. 31, 2022 334,800 725,426 9,669,217      
Balance at Dec. 31, 2021 $ 3,348 $ 7,254 $ 967 33,221,505 (39,844,531) (6,611,457)
Balance (in Shares) at Dec. 31, 2021 334,800 725,426 9,669,217      
Conversion of Series B preferred stock in connection with reverse recapitalization           7,254
Net income (loss)           (20,037,455)
Balance at Sep. 30, 2022 $ 4,725 66,150,428 (59,881,986) 6,273,167
Balance (in Shares) at Sep. 30, 2022 47,250,771      
Balance at Mar. 31, 2022 $ 3,348 $ 7,254 $ 967 33,421,662 (43,348,533) (9,915,302)
Balance (in Shares) at Mar. 31, 2022 334,800 725,426 9,669,217      
Stock-based compensation 188,657 188,657
Net income (loss) (3,356,956) (3,356,956)
Balance at Jun. 30, 2022 $ 3,348 $ 7,254 $ 967 33,610,319 (46,705,489) (13,083,601)
Balance (in Shares) at Jun. 30, 2022 334,800 725,426 9,669,217      
Stock-based compensation 235,593 235,593
Cancellation and exchange of convertible note in connection with reverse capitalization $ 530 14,548,384 14,548,914
Cancellation and exchange of convertible note in connection with reverse capitalization (in Shares) 5,299,546      
Conversion of Series A preferred stock in connection with reverse recapitalization $ (3,348) $ 476 2,872
Conversion of Series A preferred stock in connection with reverse recapitalization (in Shares) (334,800) 4,756,470      
Conversion of Series B preferred stock in connection with reverse recapitalization $ (7,254) $ 1,030 6,224
Conversion of Series B preferred stock in connection with reverse recapitalization (in Shares) (725,426) 10,306,055      
Reverse recapitalization with Cleantech Acquisition Corp, net $ 662 (669,904) (669,242)
Reverse recapitalization with Cleantech Acquisition Corp, net (in Shares) 6,619,490      
Earnout shares placed in escrow $ 750 (750)
Earnout shares placed in escrow (in Shares) 7,499,993      
Issuance of common stock for PIPE Investment $ 310 $ 30,999,690 $ 31,000,000
Issuance of common stock for PIPE Investment (in Shares) 3,100,000      
Equity issuance costs (in Shares) (12,582,000) (12,582,000)
Net income (loss) $ (13,176,497) $ (13,176,497)
Balance at Sep. 30, 2022 $ 4,725 66,150,428 (59,881,986) 6,273,167
Balance (in Shares) at Sep. 30, 2022 47,250,771      
Balance at Dec. 31, 2022 $ 4,725 68,128,196 (68,105,102) 27,819
Balance (in Shares) at Dec. 31, 2022 47,250,771      
Stock-based compensation 1,214,863 1,214,863
Exercise of stock options $ 3 59,186 59,189
Exercise of stock options (in Shares) 30,504      
Net income (loss) (14,138,665) (14,138,665)
Balance at Mar. 31, 2023 $ 4,728 69,402,245 (82,243,767) (12,836,794)
Balance (in Shares) at Mar. 31, 2023 47,281,275      
Balance at Dec. 31, 2022 $ 4,725 68,128,196 (68,105,102) 27,819
Balance (in Shares) at Dec. 31, 2022 47,250,771      
Conversion of Series B preferred stock in connection with reverse recapitalization          
Net income (loss)           (11,144,012)
Balance at Sep. 30, 2023 $ 4,986 76,567,814 (79,249,114) (2,676,314)
Balance (in Shares) at Sep. 30, 2023 49,858,194      
Balance at Mar. 31, 2023 $ 4,728 69,402,245 (82,243,767) (12,836,794)
Balance (in Shares) at Mar. 31, 2023 47,281,275      
Stock-based compensation 1,862,164 1,862,164
Exercise of warrants $ 16 338,039 338,055
Exercise of warrants (in Shares) 165,713      
Exercise of RSUs $ 30 (30)
Exercise of RSUs (in Shares) 298,531      
Exercise of stock options $ 15 283,375 283,390
Exercise of stock options (in Shares) 148,732      
Net income (loss) 20,673,440 20,673,440
Balance at Jun. 30, 2023 $ 4,789 71,885,793 (61,570,327) 10,320,255
Balance (in Shares) at Jun. 30, 2023 47,894,251      
Stock-based compensation 917,993 917,993
Settlement of liquidated damages $ 189 3,685,440 3,685,629
Settlement of liquidated damages (in Shares) 1,890,066      
Exercise of RSUs $ 3 (3)
Exercise of RSUs (in Shares) 25,276      
Exercise of stock options $ 5 78,591 78,596
Exercise of stock options (in Shares) 48,601      
Net income (loss) (17,678,787) (17,678,787)
Balance at Sep. 30, 2023 $ 4,986 $ 76,567,814 $ (79,249,114) $ (2,676,314)
Balance (in Shares) at Sep. 30, 2023 49,858,194